S.3105 - West Nile Virus and Arboviral Disease Act107th Congress (2001-2002)
|Sponsor:||Sen. Frist, William H. [R-TN] (Introduced 10/10/2002)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||10/10/2002 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Subject — Policy Area:
- View subjects
Summary: S.3105 — 107th Congress (2001-2002)All Bill Information (Except Text)
West Nile Virus and Arboviral Disease Act - Amends the Public Health Service Act to establish a temporary program for West Nile Virus and related arboviral diseases, which may include grants by the Secretary of Health and Human Services to States for the prevention and control of such diseases. Directs grant funds to be used for: (1) the development, implementation, and evaluation by States and localities of community-based, comprehensive mosquito control plans; and (2) the development and implementation of programs on medical entomology, arbovirology, and other vector-borne diseases. Includes a 50 percent matching requirement for such grants.
Introduced in Senate (10/10/2002)
Requires 85 percent of grant funds to any State to be expended locally.
Directs the Secretary, acting through the Director of the Centers for Disease Control and Prevention and with appropriate consultation, to develop a plan, together with standard operating procedures, to serve as a guideline for State and local mosquito control programs. Sets forth elements that such plan should include, including programs to: (1) identify new human cases of disease; and (2) provide laboratory support for testing. Sets a termination date of September 30, 2004, for the temporary program.
Directs the President to expand, intensify, and enhance research for various activities, including to: (1) identify and develop methods of controlling the population of insects that transmit to humans diseases that have significant adverse health consequences (including the West Nile Virus); and (2) develop rapid screening tools for West Nile Virus in blood or organs.